Presented • Larger Implications: A safe noninvasive method that could be used to identify Alzheimer's patients early in the disease process, when they could benefit the most from therapies in clinical trials designed to slow the progression of the disease.
Alzheimer's Disease
• An irreversible, progressive type of Dementia that slowly destroys memory and thinking skills, and eventually even the ability to carry out the simplest tasks. 
Experiment
• To show that patients with clinically diagnosed Alzheimer's disease are hypersensitive to the pupil-dilating effect of the acetylcholine receptor antagonist tropicamide similar to Down syndrome patients.
• Down syndrome patients beyond the age of 30 develop the same brain lesions and exhibit a related Dementia.
• Can be detected by measuring changes in heart rate or pupil size in response to these agents.
• Tropicamide is a synthetic analog of atropine, is commonly used in ophthalmology to dilate the pupil and allow examination of the fundus.
Methods
• Before Testing -Individuals seated in semi-darkened room to accommodate eyes to dim illumination.
• Test -single drop of 0.01% tropicamide was administered to one eye and a drop of a control solution (sterile water) to the other eye. -Researcher blind to which solution was being applied to which eye. -Pupil diameter data were obtained from each eye for 30-s samples at scheduled times (at 2, 8, 15, 22, 29, 41 , and 51 min.) over the course of 1 hour.
Summary Results & Conclusions
• Patients clinically diagnosed with Alzheimer's disease displayed a pronounced response to the pupildilating effect of tropicamide in comparison to the pupils of the patients treated under normal controls.
• 95% concordance between the clinical or suspected diagnosis and the results of the pupil dilation assay is consistent with the finding in our dementia clinic that 95% of patients whom we clinically diagnose with probable Alzheimer's disease. What went wrong...
• Low sample size • Did not take into account high variability -Corneal Permeability influenced by by genetic factors, the integrity of the tear film layer and the corneal epithelium, and the characteristics of the drug molecule itself -How the drop is administered, -how much blinking and tearing occur -person's state of wakefulness, alertness, or agitation
• Did not take advantage of both pupils (disregarding the effect of the actual pupil size)
